Abstract
Previous studies have demonstrated that the small permanently charged organic cation 1-methyl-4-phenylpyridinium (MPP+) is avidly taken up by rat hepatocytes. The aim of this study was to characterise the postnatal development of hepatic uptake of organic cations, using the model compound MPP+. Accumulation of [3H]MPP+by liver slices obtained from rats ranging from 1 day to 7 weeks was measured, and the effect of a series of compounds on [3H]MPP+uptake was examined. The accumulation of [3H]MPP+by liver slices was similar in adult (87.5±19.9 pmol g−l;n=7) and neonatal rats (110.6±11.5 pmol g−l;n=15). Verapamil, quinidine (100 μm) and progesterone (200 μm) produced very marked reductions on [3H]MPP+uptake at all ages, and the inhibitory effect of verapamil and quinidine was maximum in livers from 1-day-old rats. Bilirubin (200 μm) significantly reduced [3H]MPP+uptake by liver slices from 1 day, 1 week and 7-week-old rats. However, [3H]MPP+accumulation was reduced by cimetidine, vinblastine and daunomycin (100 μm) in 1-day-old rats, but the effect of these drugs disappeared as the animals age increased. These findings demonstrate that hepatic organic cation uptake capacity is remarkably high shortly after birth and suggest that at least two distinct uptake mechanisms are involved in this process. These uptake systems are the type I hepatic transporter of organic cations, active from birth to adulthood, andP-glycoprotein, active only in very young rats.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.